text: Pearce IP is proud to announce that Special Counsel, Patent Attorney and Trade Mark Attorney, Jennifer Enmon PhD, JD has been recognised by Lawyer Monthly (Women in Law Awards 2021) as Patents Lawyer of the Year for Australasia.
  Pearce IP’s founding Principal, Patent Lawyer Naomi Pearce says:
  “I am delighted that Jennifer has been recognised as Lawyer Monthly Patents Lawyer of the Year for Australasia. Jennifer is one of a kind, and a stand-out. She has a PhD in chemistry (emphasis biochemistry), is a registered lawyer in California, New York and the district of Columbia, is registered as a patent attorney in the US, AU and NZ, and qualified as a patent attorney in Europe. With her unique and truly global qualifications and experience, Jennifer provides her clients with the benefit of her experience gained as both a litigator and a prosecutor. She is a highly talented professional who is respected by clients and colleagues alike, and this recognition is very well deserved.”
  Pearce IP is a boutique firm offering intellectual property specialist lawyers, patent attorneys and trade mark attorneys to the pharmaceutical, biopharmaceutical and life sciences industries. Pearce IP leaders are well recognised as leading patent practitioners. Pearce IP is a finalist for ‘Intellectual Property Team of the Year’ in the 2021 Lawyers Weekly Australian Law Awards, and is ranked in IAM Patent 1000 for both legal and attorney patent services. Team members are also listed in IAM Patent 1000 and IAM Strategy 300, have been awarded Patent Stars & Notable Practitioner listings by MIP, ranked in Doyles Guide, and listed in WIPR Leaders, 5 Star IP Lawyers, and Australasian Lawyer 5 Star Awards.
  Jennifer Enmon PhD, JD
  Special Counsel Patent Attorney (Registered in US, AU & NZ; EU Qualified) Trade Mark Attorney, AU & NZ
  Jennifer has been advising clients on life sciences related patent matters for over 15 years.
  Jennifer is a registered Patent Attorney in Australia, New Zealand and the United States and is a qualified Patent Attorney in Europe. She is also a registered Trade Mark Attorney in Australia and New Zealand.
  Google+
  LinkedIn
  Naomi Pearce
  Executive Lawyer, Patent Attorney & Trade Mark Attorney
  Naomi is listed in IAM Patent 1000 as one of Australia's leading patent litigators, and in IAM Strategy 300: The World's Leading IP Strategists. Underpinning Naomi’s legal work is a deep understanding of the pharma/biopharma industries, resulting from first hand experience and knowledge as VP of IP in-house at global pharma giants, and Partner of a top-tier international law firm.
  Facebook
  Twitter
  Google+
  LinkedIn
  Print Page
  Get our Pearce IP Blogs & BioBlast® sent directly to your inbox
  Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.
  Subscribe here
  Our Latest News
  Pearce IP BioBlast®: w/e 26 November 2021
  by Naomi Pearce, Jennifer Enmon PhD, Emily Bristow | Nov 29, 2021
  21 Nov 21 | CN | Innovent released the results of a Ph III study of sintilimab and BYVASDA® (bevacizumab biosimilar) combined with chemotherapy in...
  read more
  Breaking News – Parliament delivers early Christmas present for Health Care
  by Katrina Crooks, Kristy McCamley PhD | Nov 26, 2021
  In the last sitting of Parliament for 2021, the House of Representatives delivered the long-awaited Zimmerman Report, more formally entitled “The...
  read more
  Naomi Pearce is Lawyers Weekly WIL Partner of the Year 2021
  by Pearce IP | Nov 26, 2021
  Pearce IP is proud to announce that Founding Principal and Executive Lawyer, Patent & Trade Mark Attorney, Naomi Pearce, was awarded the title...
  read more
  Pearce IP BioBlast®: w/e 19 November 2021
  by Naomi Pearce, Jennifer Enmon PhD, Emily Bristow | Nov 22, 2021
  15 Nov 21 | EU | Celltrion announced that the EC has approved Regkirona® (regdanvimab, CT-P59) for adults with COVID-19 who do not require...
  read more
  Hold onto your Hats! – Expedited Patent Litigation in Australia
  by Katrina Crooks, Naomi Pearce, Kristy McCamley PhD | Nov 16, 2021
  The speed of getting a case to trial is a key metric of any litigation system. Pharmaceutical patent litigation often plays out on the cusp of...
  read more
  Pearce IP BioBlast®: w/e 12 November 2021
  by Naomi Pearce, Jennifer Enmon PhD, Emily Bristow | Nov 16, 2021
  09 Nov 21 | Coherus BioSciences reported its Q3 2021 financial results. Coherus announced that FDA review of CHS-201 (proposed adalimumab...
  read more
  SUBSCRIBE TO PEARCE IP
  Sign up to our latest news
  Receive our Pearce IP Blog and weekly BioBlast® via email.
  SUBSCRIBE
  Our People
  Our Capabilities
  News
  Blog
  BioBlast®
  Contact Us
  Follow
  Copyright © 2021 Pearce IP. All Rights Reserved. Privacy Statement
  Contact Us
  Email: info@pearceIP.law
  Tel: +61 (0) 2 9023 9988
  For any general inquiries, please fill in the following contact form:
  How did you hear about us? ---RecommendationRanking or awardSearch EngineArticle or other publicationOther
  Subscribe to our BioBlast®
  Fill in the form below to receive our BioBlast™ Updates, Pearce IP Blog and other relevant industry updates.